Robin Cohen

With over 25 years of experience in the pharmaceutical industry, Robin Cohen is a senior level leader with a strong track record in biotech commercialization. Prior to joining aVaxziPen, he worked at Janssen Cilag (Johnson & Johnson) launching ground-breaking therapeutic products across a range of the therapeutic areas from oncology to HIV and hepatitis. In 2021, he joined Emergex Vaccines with responsibility for its commercial strategy, joining aVaxziPen in February 2023 where he leads commercial development and partnering.